A year ago, overconfidence in the market led to a significan...

A year ago, overconfidence in the market led to a significant drop in share price compared to the EPS decline. Despite recent downturns, the stock has seen a 2% annual return over five years. However, Jinling Pharmaceutical's investment analysis reveals 3 warning signs, one of which is significant.